Nanospectra Biosciences, Inc. — Biomedical Watch V2

Traitements5programmes

Essais3liés

Publications0liées

SourceDBlocale

Traitements

5

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
AuroLase TherapyThis is an open-label, single-center, single-dose efficacy pilot study of AuroLase Therapy in the treatment of subjects with primary and/or metastatic tumors of the lung where there is airway obstruction. In this study patients will be given a systemic IV infusion of particles and a subsequent escalating dose of laser radiation delivered by optical fiber via bronchoscopy.	Cancer	Non applicable	À vérifier	United States	À vérifier
AuroShell particle infusionTo determine the efficacy of using MRI/US fusion imaging technology to direct focal ablation of prostate tissue using nanoparticle-directed laser irradiation.	Cancer	Non applicable	À vérifier	United States	À vérifier
AuroShell particle infusionTo determine the efficacy of using MRI/US fusion imaging technology to direct focal ablation of prostate tissue using nanoparticle-directed laser irradiation.	Cancer	Non applicable	À vérifier	United States	À vérifier
AuroShell particle infusionTo determine the efficacy of using MRI/US fusion imaging technology to direct focal ablation of prostate tissue using nanoparticle-directed laser irradiation.	Cancer	Non applicable	À vérifier	United States	À vérifier
AuroLase TherapyThis is an open-label, single-center, single-dose efficacy pilot study of AuroLase Therapy in the treatment of subjects with primary and/or metastatic tumors of the lung where there is airway obstruction. In this study patients will be given a systemic IV infusion of particles and a subsequent escalating dose of laser radiation delivered by optical fiber via bronchoscopy.	Cancer	Non applicable	À vérifier	United States	À vérifier

Essais cliniques

3

Molécule	Indication / population	Phase	NCT	Titre	Statut
AuroLase Therapy	Cancer	Non applicable	NCT01679470	Efficacy Study of AuroLase Therapy in Subjects With Primary and/or Metastatic Lung Tumors	TERMINATED
AuroShell particle infusion	Cancer	Non applicable	NCT02680535	MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue	COMPLETED
AuroShell particle infusion	Cancer	Non applicable	NCT04240639	An Extension Study MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue	UNKNOWN

Publications

0

Molécule	Indication / population	Titre	Journal	Date
Aucune publication.